Clinical trial / 2011
In a pilot study, weaning infants to highly hydrolyzed formula reduced cumulative incidence of diabetes-associated autoantibodies by ~50% up to age 10.
The TRIGR study evaluates whether weaning to an extensively hydrolyzed formula decreases the risk of type 1 diabetes later in childhood. In a pilot study, weaning to a highly hydrolyzed formula decreased the cumulative incidence of one or more diabetes-associated autoantibodies by ≈ 50% by mean age 4.7 years, confirmed in follow-up to 10 years of age. The full-scale trial enrolled 2159 eligible infants with risk-conferring HLA genotypes across 77 centers in 15 countries to compare hydrolyzed casein with standard cow milk-based formula for 6-8 months (minimum 2 months exposure). Eighty percent of participants were exposed to the study formula, with an 87% retention rate over the first 5 years and 94% protocol compliance; the code opens in 2017.
- Study type
- Randomized double-blind controlled intervention trial
- Who was studied
- 5606 recruited newborn infants with an affected family member; 2159 enrolled with risk-conferring HLA genotypes
- What was measured
- Risk of type 1 diabetes and diabetes-associated autoantibodies
THE PAPER
Early feeding and risk of type 1 diabetes: experiences from the Trial to Reduce Insulin-dependent diabetes mellitus in the Genetically at Risk (TRIGR).
Knip M, Virtanen SM, Becker D, Dupré J, Krischer JP, Åkerblom HK, TRIGR Study Group. Am J Clin Nutr, 2011.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.